Stable Isotope Labelled Ocaratuzumab Biosimilar – Anti-MS4A1/CD20 mAb – Research Grade

Reference: PX-TA1298-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Ocaratuzumab Biosimilar - Anti-MS4A1/CD20 mAb - Research Grade
SourceCAS 1169956-08-4
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsAME-133v,LY2469298
ReferencePX-TA1298-SIL
Related ProductsPX-P3060
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Ocaratuzumab Biosimilar - Anti-MS4A1/CD20 mAb - Research Grade

General information on Anti-MS4A1/CD20[Homo sapiens] (Ocaratuzumab) Monoclonal Antibody

Ocaratuzumab is used for the treatment of cancer and autoimmune disorders. The antibody has been designed with an increased affinity to the CD20 antigen on B-lymphocytes, to enhance antibody-dependent cell-mediated cytotoxicity (ADCC).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Ocaratuzumab Biosimilar – Anti-MS4A1/CD20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products